Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03690466 · ClinicalTrials.gov registry record · NA
Ultrasound Treatment of Rheumatoid Arthritis
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT03690466 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 19 participants.
The verdict
NCT03690466, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The research objective of the pilot study is to assess early feasibility of safety and efficacy of spleen ultrasound stimulation in the treatment of rheumatoid arthritis (RA) in a blinded and randomized controlled trial. Specific Aims include: * Measure RA disease activity and functional/biomarker metrics during and after a 2- week course of spleen-directed daily ultrasound treatments (within-arm and between-arm assessments); and * Monitor adverse events during and after daily ultrasound treatments.
Interventions
- DEVICE Study device treatment
- DEVICE Sham device treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2018-10-03 |
| Est. Completion | 2022-04-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03690466
The ClinicalTrials.gov registry entry for NCT03690466 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Study device treatment is the first listed.
NCT03690466 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03690466 about?
NCT03690466 is a clinical study titled "Ultrasound Treatment of Rheumatoid Arthritis". The research objective of the pilot study is to assess early feasibility of safety and efficacy of spleen ultrasound stimulation in the treatment of rheumatoid arthritis (RA) in a blinded and randomized controlled trial. Specific Aims include: * Measure RA disease activity and functional/biomarker ...
What is the current status of trial NCT03690466?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2018-10-03. Estimated completion is 2022-04-28.
What interventions are being tested in trial NCT03690466?
The interventions under investigation include: Study device treatment (DEVICE), Sham device treatment (DEVICE).
Who is sponsoring clinical trial NCT03690466?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.